Jalpa Doshi

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States
    Jalpa A Doshi
    Perelman School of Medicine, University of Pennsylvania, USA
    J Am Acad Child Adolesc Psychiatry 51:990-1002.e2. 2012
  2. ncbi Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    BMC Health Serv Res 10:245. 2010
  3. ncbi Prevalence and trends in obesity among aged and disabled U.S. Medicare beneficiaries, 1997-2002
    Jalpa A Doshi
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Health Aff (Millwood) 26:1111-7. 2007
  4. ncbi Drug benefit generosity and essential medication use among Medicare-eligible retirees
    Jalpa A Doshi
    Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Am J Manag Care 13:425-31. 2007
  5. ncbi Analyses of cost data in economic evaluations conducted alongside randomized controlled trials
    Jalpa A Doshi
    Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
    Value Health 9:334-40. 2006
  6. ncbi Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans
    Jalpa A Doshi
    Center for Health Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
    Circulation 119:390-7. 2009
  7. ncbi The impact of drug coverage on COX-2 inhibitor use in Medicare
    Jalpa A Doshi
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
    Health Aff (Millwood) . 2004
  8. ncbi National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey
    Jalpa A Doshi
    School of Medicine, Universityof Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Geriatr Soc 53:438-43. 2005
  9. ncbi Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis
    Jalpa A Doshi
    University of Pennsylvania School of Medicine and Leonard Davis Institute of Health Economics, Philadelphia, PA 19104 6021, USA
    Arthritis Care Res (Hoboken) 62:354-61. 2010
  10. ncbi The shape of things to come: obesity, aging, and disability
    Dawn E Alley
    Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
    LDI Issue Brief 13:1-4. 2008

Detail Information

Publications27

  1. ncbi Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States
    Jalpa A Doshi
    Perelman School of Medicine, University of Pennsylvania, USA
    J Am Acad Child Adolesc Psychiatry 51:990-1002.e2. 2012
    ..This article comprehensively reviews studies reporting ADHD-related incremental (excess) costs for children/adolescents and adults and presents estimates of annual national incremental costs of ADHD...
  2. ncbi Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    BMC Health Serv Res 10:245. 2010
    ..This study intends to assess the performance of the CMS-HCC risk adjustment method and to compare it to the Charlson and Elixhauser comorbidity measures in predicting in-hospital and six-month mortality in Medicare beneficiaries...
  3. ncbi Prevalence and trends in obesity among aged and disabled U.S. Medicare beneficiaries, 1997-2002
    Jalpa A Doshi
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Health Aff (Millwood) 26:1111-7. 2007
    ..4 percent and 32.5 percent, respectively, in 1997. Using 2002 data, we estimate that three million beneficiaries would be eligible for bariatric surgery coverage under current Medicare policy...
  4. ncbi Drug benefit generosity and essential medication use among Medicare-eligible retirees
    Jalpa A Doshi
    Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Am J Manag Care 13:425-31. 2007
    ..To examine the association between generosity of drug coverage and essential cardiovascular medication use among retired seniors...
  5. ncbi Analyses of cost data in economic evaluations conducted alongside randomized controlled trials
    Jalpa A Doshi
    Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
    Value Health 9:334-40. 2006
    ..The objective of this article is to evaluate the statistical methods used for analysis of cost data in economic evaluations conducted alongside randomized controlled trials...
  6. ncbi Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans
    Jalpa A Doshi
    Center for Health Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
    Circulation 119:390-7. 2009
    ..We examined the impact of the copayment increase on lipid-lowering medication adherence...
  7. ncbi The impact of drug coverage on COX-2 inhibitor use in Medicare
    Jalpa A Doshi
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
    Health Aff (Millwood) . 2004
    ..However, this risk differential in COX-2 use disappears among those with the most generous coverage. Potential overuse of costly medications should be addressed as the Medicare drug benefit is being phased in...
  8. ncbi National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey
    Jalpa A Doshi
    School of Medicine, Universityof Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Geriatr Soc 53:438-43. 2005
    ..To provide the first nationwide estimates of medication use in nursing homes (NHs) and to introduce a new data set for examining drug use in long-term care facilities...
  9. ncbi Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis
    Jalpa A Doshi
    University of Pennsylvania School of Medicine and Leonard Davis Institute of Health Economics, Philadelphia, PA 19104 6021, USA
    Arthritis Care Res (Hoboken) 62:354-61. 2010
    ....
  10. ncbi The shape of things to come: obesity, aging, and disability
    Dawn E Alley
    Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
    LDI Issue Brief 13:1-4. 2008
    ..This issue Brief summarizes two studies that examine the prevalence of obesity over time in the elderly and disabled, and the changing relationship of obesity and disability...
  11. ncbi Clinical trial-based cost-effectiveness analyses of antipsychotic use
    Daniel Polsky
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
    Am J Psychiatry 163:2047-56. 2006
    ..Given limited health care resources, assessment of the value for the cost of second-generation antipsychotics relative to first-generation antipsychotics is critical for resource-allocation decisions...
  12. ncbi The health effects of Medicare for the near-elderly uninsured
    Daniel Polsky
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Health Serv Res 44:926-45. 2009
    ..To determine whether Medicare enrollment at age 65 has an effect on the health trajectory of the near-elderly uninsured...
  13. ncbi Long-term risk for depressive symptoms after a medical diagnosis
    Daniel Polsky
    Division of General Internal Medicine, University of Pennsylvania Medical Center, Philadelphia, USA
    Arch Intern Med 165:1260-6. 2005
    ..This study examines the risk of development of significant depressive symptoms after a new diagnosis of cancer, diabetes, hypertension, heart disease, arthritis, chronic lung disease, or stroke...
  14. ncbi Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
    David S Mandell
    University of Pennsylvania School of Medicine, Department of Psychiatry, Philadelphia, PA 19104, USA
    Pediatrics 121:e441-8. 2008
    ....
  15. ncbi Depression and retirement in late middle-aged U.S. workers
    Jalpa A Doshi
    University of Pennsylvania, Blockley Hall, Rm 1222, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Health Serv Res 43:693-713. 2008
    ..To determine whether late middle-aged U.S. workers with depression are at an increased risk for retirement...
  16. ncbi A test of financial incentives to improve warfarin adherence
    Kevin G Volpp
    Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
    BMC Health Serv Res 8:272. 2008
    ..Novel methods are needed to improve adherence for warfarin. We conducted two pilot studies to determine whether a lottery-based daily financial incentive is feasible and improves warfarin adherence and anticoagulation control...
  17. ncbi Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes
    Bruce Stuart
    Pharmaceutical Health Services Research Department, The Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Med Care 50:913-9. 2012
    ..It is not known whether low-income subsidies (LIS) under Medicare Part D help beneficiaries overcome impediments to medication use associated with poor socioeconomic status and high disease burden...
  18. ncbi Predictability of prescription drug expenditures for Medicare beneficiaries
    Marian V Wrobel
    University of Pennsylvania School of Medicine, USA
    Health Care Financ Rev 25:37-46. 2003
    ..Adding lagged drug expenditures more than doubled predictive power to 55 percent. These results are discussed in the context of forecasting, and risk adjustment for the proposed new Medicare drug benefit...
  19. ncbi The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
    William F McGhan
    University of the Sciences, 600 South 43rd Street, Philadelphia, PA, USA
    Value Health 12:1086-99. 2009
    ..They were drawn from industry, academia, consulting organizations, and advisors to governments and came from Japan, the Netherlands, Canada and the United States...
  20. ncbi Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease
    Bruce Stuart
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, 515 W Lombard Street, Room 157, Baltimore, MD 21201, USA
    Clin Ther 26:1688-99. 2004
    ..Any possible impact would be most apparent in patients with medication-sensitive disease conditions, such as chronic obstructive pulmonary disease (COPD)...
  21. ncbi The quality of antipsychotic drug prescribing in nursing homes
    Becky A Briesacher
    Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester 01605, USA
    Arch Intern Med 165:1280-5. 2005
    ....
  22. ncbi Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending
    Becky A Briesacher
    Division of Geriatric Medicine, University of Massachusetts Medical School, Worchester, MA 01605, USA
    Health Serv Res 40:1279-96. 2005
    ..This does not necessarily mean that drug therapy does not substitute for or complement other medical treatments, but rather that neither effect predominates across the Medicare population as a whole...
  23. ncbi Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making
    Robert A Rosenheck
    Department of Psychiatry, Yale Medical School, New Haven, CT 06516, USA
    Psychiatr Serv 59:515-20. 2008
    ..High expenditures on these medications are thus likely to continue without concomitant gains for public health...
  24. ncbi Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries
    Sachin J Kamal-Bahl
    University of Maryland Baltimore, School of Pharmacy, Maryland 21201, USA
    J Am Geriatr Soc 51:1099-104. 2003
    ....
  25. ncbi Differential loss to follow-up by insurance status in the Health and Retirement Study: implications for national estimates on health insurance coverage
    Daniel Polsky
    Arch Intern Med 165:2537-8; author reply 2538. 2005
  26. ncbi Policy implications of CATIE
    Robert A Rosenheck
    Psychiatr Serv 59:695. 2008
  27. ncbi Antihypertensive use and adherence and blood pressure stress response among black caregivers and non-caregivers
    Jalpa A Doshi
    University of Maryland, School of Pharmacy, Baltimore, MD 21201, USA
    Appl Nurs Res 16:266-77. 2003
    ..These findings contradict previous findings among white caregivers and non-caregivers and suggest different practice implications...

Research Grants5

  1. Life Cycle Effects of Health Insurance on Elderly Health
    Jalpa Doshi; Fiscal Year: 2006
    ..We will use these estimates to simulate the effect of changes in the age of Medicare eligibility on health, medical service use and Medicare expenditure. ..
  2. Impact of Medicaid Prescription Copayments in Patients with Schizophrenia
    Jalpa Doshi; Fiscal Year: 2007
    ..The findings of our study will help inform policymakers about the intended and unintended consequences of prescription copayments in Medicaid patients with schizophrenia. ..
  3. Impact of Medicaid Prescription Copayments in Patients with Schizophrenia
    Jalpa Doshi; Fiscal Year: 2009
    ..The findings of our study will help inform policymakers about the intended and unintended consequences of prescription copayments in Medicaid patients with schizophrenia. ..
  4. Impact of Medicare Part D in Dual Eligibles with Schizophrenia
    Jalpa A Doshi; Fiscal Year: 2010
    ..They will help guide design and refine policies surrounding Part D so as to provide a balance between medication access and costs in such vulnerable patients who can least afford to be without needed medications. ..